How much funding has MapLight Therapeutics raised?

MapLight Therapeutics has raised $372.5M in total funding, most recently a Series D round.

Who are MapLight Therapeutics's investors?

MapLight Therapeutics's investors include Forbion Capital Partners, Novo Holdings A/S.

When was MapLight Therapeutics founded?

MapLight Therapeutics was founded in 2018.

Where is MapLight Therapeutics headquartered?

MapLight Therapeutics is headquartered in San Francisco, California, United States.

What industry is MapLight Therapeutics in?

MapLight Therapeutics operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does MapLight Therapeutics have?

MapLight Therapeutics has 51-200 employees.

MapLight Therapeutics

IPO

Creating breakthrough innovative therapeutics for serious CNS disorders

Public · San Francisco, United States · Founded 2018 · $372.5M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 51–200
Founded: 2018
Business Model: Other
Website: maplighttx.com

Total Funding: $372.5M
Last Round: $372.5M Series DJul 2025
Rounds: 1
Type: Public

About

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for central nervous system (CNS) disorders using an integrated computational and experimental platform.

Summary

MapLight Therapeutics is an Artificial Intelligence company based in San Francisco, United States, founded in 2018. It has raised $372.5M in total across 1 round, most recently a $372.5M Series D round in Jul 2025. Investors include Forbion Capital Partners and Novo Holdings A/S.

LinkedIn X (Twitter)GitHub